|
J Biol Chem, Vol. 274, Issue 43, 30799-30810, October 22, 1999
The Pharmacological and Functional Characteristics of the
Serotonin 5-HT3A Receptor Are Specifically Modified by a
5-HT3B Receptor Subunit
Adrienne E.
Dubin,
Rene
Huvar,
Michael R.
D'Andrea§,
Jayashree
Pyati,
Jessica Y.
Zhu,
K. C.
Joy,
Sandy J.
Wilson,
Jose E.
Galindo,
Charles A.
Glass,
Lin
Luo,
Michael R.
Jackson,
Timothy W.
Lovenberg, and
Mark G.
Erlander
From the R. W. Johnson Pharmaceutical Research Institute, San
Diego, California 92121 and the § R. W. Johnson
Pharmaceutical Research Institute,
Spring House, Pennsylvania 19477-0776
While homomers containing
5-HT3A subunits form functional ligand-gated
serotonin (5-HT) receptors in heterologous expression systems (Jackson,
M. B., and Yakel, J. L. (1995) Annu. Rev.
Physiol. 57, 447-468; Lambert, J. J., Peters, J. A.,
and Hope, A. G. (1995) in Ligand-Voltage-Gated Ion
Channels (North, R., ed) pp. 177-211, CRC Press, Inc., Boca
Raton, FL), it has been proposed that native receptors may exist as
heteromers (Fletcher, S., and Barnes, N. M. (1998) Trends
Pharmacol. Sci. 19, 212-215). We report the cloning of a subunit
5-HT3B with ~44% amino acid identity to
5-HT3A that specifically modified 5-HT3A
receptor kinetics, voltage dependence, and pharmacology. Co-expression
of 5-HT3B with 5-HT3A modified the duration of
5-HT3 receptor agonist-induced responses, linearized the
current-voltage relationship, increased agonist and antagonist affinity, and reduced cooperativity between subunits. Reverse transcriptase-polymerase chain reaction in situ
hybridization revealed co-localization of both 5-HT3B and
5-HT3A in a population of neurons in the amygdala,
telencephalon, and entorhinal cortex. Furthermore, 5-HT3A
and 5-HT3B mRNAs were expressed in spleen and
intestine. Our data suggest that 5-HT3B might contribute to tissue-specific functional changes in 5-HT3-mediated
signaling and/or modulation.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Z. Deeb, D. Sharp, and T. G. Hales
Direct Subunit-Dependent Multimodal 5-Hydroxytryptamine3 Receptor Antagonism by Methadone
Mol. Pharmacol.,
April 1, 2009;
75(4):
908 - 917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe
Endocannabinoid-Mediated Control of Synaptic Transmission
Physiol Rev,
January 1, 2009;
89(1):
309 - 380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Rojas, M. Stathis, A. G. Thomas, E. B. Massuda, J. Alt, J. Zhang, E. Rubenstein, S. Sebastiani, S. Cantoreggi, S. H. Snyder, et al.
Palonosetron Exhibits Unique Molecular Interactions with the 5-HT3 Receptor
Anesth. Analg.,
August 1, 2008;
107(2):
469 - 478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Noam, W. J. Wadman, and J. A. van Hooft
On the voltage-dependent Ca2+ block of serotonin 5-HT3 receptors: a critical role of intracellular phosphates
J. Physiol.,
August 1, 2008;
586(15):
3629 - 3638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Livesey, M. A. Cooper, T. Z. Deeb, J. E. Carland, J. Kozuska, Tim. G. Hales, J. J. Lambert, and J. A. Peters
Structural Determinants of Ca2+ Permeability and Conduction in the Human 5-Hydroxytryptamine Type 3A Receptor
J. Biol. Chem.,
July 11, 2008;
283(28):
19301 - 19313.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-Q. Hu and R. W. Peoples
The 5-HT3B Subunit Confers Spontaneous Channel Opening and Altered Ligand Properties of the 5-HT3 Receptor
J. Biol. Chem.,
March 14, 2008;
283(11):
6826 - 6831.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-Q. Hu and R. W. Peoples
Arginine 246 of the Pretransmembrane Domain 1 Region Alters 2,2,2-Trichloroethanol Action in the 5-Hydroxytryptamine3A Receptor
J. Pharmacol. Exp. Ther.,
March 1, 2008;
324(3):
1011 - 1018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. Fink and M. Gothert
5-HT Receptor Regulation of Neurotransmitter Release
Pharmacol. Rev.,
December 1, 2007;
59(4):
360 - 417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cheng, K. A. Bollan, S. M. Greenwood, A. J. Irving, and C. N. Connolly
Differential Subcellular Localization of RIC-3 Isoforms and Their Role in Determining 5-HT3 Receptor Composition
J. Biol. Chem.,
September 7, 2007;
282(36):
26158 - 26166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Niesler, J. Walstab, S. Combrink, D. Moller, J. Kapeller, J. Rietdorf, H. Bonisch, M. Gothert, G. Rappold, and M. Bruss
Characterization of the Novel Human Serotonin Receptor Subunits 5-HT3C,5-HT3D, and 5-HT3E
Mol. Pharmacol.,
July 1, 2007;
72(1):
8 - 17.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Rusch, B. Musset, H. Wulf, A. Schuster, and D. E. Raines
Subunit-Dependent Modulation of the 5-Hydroxytryptamine Type 3 Receptor Open-Close Equilibrium by n-Alcohols
J. Pharmacol. Exp. Ther.,
June 1, 2007;
321(3):
1069 - 1074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Yan, J. K. Meyer, and M. M. White
Mapping Residues in the Ligand-Binding Domain of the 5-HT3 Receptor onto d-Tubocurarine Structure
Mol. Pharmacol.,
August 1, 2006;
70(2):
571 - 578.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zhang, N. A. White, F. S. Soti, W. R. Kem, and T. K. Machu
N-Terminal Domains in Mouse and Human 5-Hydroxytryptamine3A Receptors Confer Partial Agonist and Antagonist Properties to Benzylidene Analogs of Anabaseine
J. Pharmacol. Exp. Ther.,
June 1, 2006;
317(3):
1276 - 1284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Solt, R. J. Stevens, P. A. Davies, and D. E. Raines
General Anesthetic-Induced Channel Gating Enhancement of 5-Hydroxytryptamine Type 3 Receptors Depends on Receptor Subunit Composition
J. Pharmacol. Exp. Ther.,
November 1, 2005;
315(2):
771 - 776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. P. Barrera, P. Herbert, R. M. Henderson, I. L. Martin, and J. M. Edwardson
Atomic force microscopy reveals the stoichiometry and subunit arrangement of 5-HT3 receptors
PNAS,
August 30, 2005;
102(35):
12595 - 12600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N M Barnes
5-HT3 receptor antagonists ameliorate fatigue: so much potential, so little knowledge!
Gut,
August 1, 2005;
54(8):
1056 - 1057.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Yan and M. M. White
Spatial Orientation of the Antagonist Granisetron in the Ligand-Binding Site of the 5-HT3 Receptor
Mol. Pharmacol.,
August 1, 2005;
68(2):
365 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Stevens, D. Rusch, K. Solt, D. E. Raines, and P. A. Davies
Modulation of Human 5-Hydroxytryptamine Type 3AB Receptors by Volatile Anesthetics and n-Alcohols
J. Pharmacol. Exp. Ther.,
July 1, 2005;
314(1):
338 - 345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Dubin, N. Nasser, J. Rohrbacher, A. N. Hermans, R. Marrannes, C. Grantham, K. Van Rossem, M. Cik, S. R. Chaplan, D. Gallacher, et al.
Identifying Modulators of hERG Channel Activity Using the PatchXpress(R) Planar Patch Clamp
J Biomol Screen,
March 1, 2005;
10(2):
168 - 181.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bhattacharya, H. Dang, Q.-M. Zhu, B. Schnegelsberg, N. Rozengurt, G. Cain, R. Prantil, D. A. Vorp, N. Guy, D. Julius, et al.
Uropathic Observations in Mice Expressing a Constitutively Active Point Mutation in the 5-HT3A Receptor Subunit
J. Neurosci.,
June 16, 2004;
24(24):
5537 - 5548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. V. Harrell and A. M. Allan
Improvements in Hippocampal-Dependent Learning and Decremental Attention in 5-HT3 Receptor Overexpressing Mice
Learn. Mem.,
September 1, 2003;
10(5):
410 - 419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Sessoms-Sikes, M. E. Hamilton, L.-X. Liu, D. M. Lovinger, and T. K. Machu
A Mutation in Transmembrane Domain II of the 5-Hydroxytryptamine3A Receptor Stabilizes Channel Opening and Alters Alcohol Modulatory Actions
J. Pharmacol. Exp. Ther.,
August 1, 2003;
306(2):
595 - 604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. W. Boyd, A. I. Doward, E. F. Kirkness, N. S. Millar, and C. N. Connolly
Cell Surface Expression of 5-Hydroxytryptamine Type 3 Receptors Is Controlled by an Endoplasmic Reticulum Retention Signal
J. Biol. Chem.,
July 18, 2003;
278(30):
27681 - 27687.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-B. Tremblay, R. Kaiser, O. Sezer, N. Rosler, C. Schelenz, K. Possinger, I. Roots, and J. Brockmoller
Variations in the 5-Hydroxytryptamine Type 3B Receptor Gene as Predictors of the Efficacy of Antiemetic Treatment in Cancer Patients
J. Clin. Oncol.,
June 1, 2003;
21(11):
2147 - 2155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. V. Rothlin, M. I. Lioudyno, A. F. Silbering, P. V. Plazas, M. E. G. Casati, E. Katz, P. S. Guth, and A. B. Elgoyhen
Direct Interaction of Serotonin Type 3 Receptor Ligands with Recombinant and Native alpha 9alpha 10-Containing Nicotinic Cholinergic Receptors
Mol. Pharmacol.,
May 1, 2003;
63(5):
1067 - 1074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Chaplan, H.-Q. Guo, D. H. Lee, L. Luo, C. Liu, C. Kuei, A. A. Velumian, M. P. Butler, S. M. Brown, and A. E. Dubin
Neuronal Hyperpolarization-Activated Pacemaker Channels Drive Neuropathic Pain
J. Neurosci.,
February 15, 2003;
23(4):
1169 - 1178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-T. Liu, S. Rayport, Y. Jiang, D. L. Murphy, and M. D. Gershon
Expression and function of 5-HT3 receptors in the enteric neurons of mice lacking the serotonin transporter
Am J Physiol Gastrointest Liver Physiol,
December 1, 2002;
283(6):
G1398 - G1411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. N Sudweeks, J. A van Hooft, and J. L Yakel
Serotonin 5-HT3 receptors in rat CA1 hippocampal interneurons: functional and molecular characterization
J. Physiol.,
November 1, 2002;
544(3):
715 - 726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Morales and S.-D. Wang
Differential Composition of 5-Hydroxytryptamine3 Receptors Synthesized in the Rat CNS and Peripheral Nervous System
J. Neurosci.,
August 1, 2002;
22(15):
6732 - 6741.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Panicker, H. Cruz, C. Arrabit, and P. A. Slesinger
Evidence for a Centrally Located Gate in the Pore of a Serotonin-Gated Ion Channel
J. Neurosci.,
March 1, 2002;
22(5):
1629 - 1639.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. DELANY, M. HURLE, P. FACER, T. ALNADAF, C. PLUMPTON, I. KINGHORN, C. G. SEE, M. COSTIGAN, P. ANAND, C. J. WOOLF, et al.
Identification and characterization of a novel human vanilloid receptor-like protein, VRL-2
Physiol Genomics,
January 19, 2001;
4(3):
165 - 174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Gunthorpe and S. C. R. Lummis
Conversion of the Ion Selectivity of the 5-HT3A Receptor from Cationic to Anionic Reveals a Conserved Feature of the Ligand-gated Ion Channel Superfamily
J. Biol. Chem.,
March 30, 2001;
276(14):
10977 - 10983.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|